Dextrose 5% in Water (D5W)

Comprehensive Clinical Guide: Dextrose 5% in Water (D5W)

1. Introduction and Overview

Dextrose 5% in Water (D5W) is a foundational intravenous (IV) solution utilized ubiquitously across clinical settings, from emergency departments and intensive care units to perioperative suites. It is classified as a sterile, non-pyrogenic, parenteral fluid intended for intravenous administration.

Chemically, D5W consists of 50 grams of D-glucose monohydrate per liter of sterile water. While it is technically classified as an isotonic solution in the container (with an osmolarity of approximately 252 mOsm/L), it is physiologically classified as a hypotonic solution. This occurs because, once infused, the dextrose is rapidly metabolized by the body into carbon dioxide and water, leaving behind free water that redistributes across all fluid compartments.

This guide serves as an authoritative reference for clinicians, nurses, and pharmacists regarding the pharmacodynamics, clinical application, and safety profiles of D5W.

2. Technical Specifications and Mechanism of Action

2.1 Pharmacodynamics

The primary therapeutic utility of D5W is the provision of free water and caloric supplementation. Unlike crystalloids containing electrolytes (such as Normal Saline or Lactated Ringer’s), D5W provides no sodium, chloride, or potassium.

1. Metabolism: Upon entry into the systemic circulation, glucose is rapidly metabolized via oxidative pathways into CO2 and H2O.
2. Osmotic Shift: Because the dextrose is metabolized, the effective tonicity of the solution drops significantly. The resulting free water moves from the intravascular space into the intracellular and interstitial compartments via osmosis.
3. Caloric Value: D5W provides approximately 170 kcal/L, which is insufficient for total parenteral nutrition (TPN) but helpful in preventing ketosis in patients who are temporarily NPO (nothing by mouth).

2.2 Pharmacokinetics

• Absorption: Immediate bioavailability (Intravenous route).
• Distribution: Once metabolized, the water distributes throughout the total body water (approximately 60% of body weight).
• Metabolism: Hepatic and systemic cellular metabolism via glycolysis and the Krebs cycle.
• Elimination: Excreted as CO2 (respiratory) and water (renal/insensible loss).

3. Clinical Indications and Usage

D5W is indicated for various clinical scenarios, primarily involving fluid and nutrient management.

3.1 Dosage Guidelines

Dosage is highly individualized based on the patient's age, weight, clinical condition, and fluid/electrolyte status.

• Adults: Typical maintenance ranges from 1.5 to 2.5 liters per 24 hours, depending on metabolic needs.
• Pediatrics: Dosage must be strictly calculated based on the Holliday-Segar formula (100/50/20 rule) to avoid fluid overload or electrolyte disturbances.
• Maximum Rate: Infusion rates must be monitored to prevent hyperglycemia. In patients with metabolic stress, the glucose infusion rate (GIR) should generally not exceed 4–6 mg/kg/min.

4. Risks, Side Effects, and Contraindications

4.1 Contraindications

• Intracranial/Intraspinal Hemorrhage: D5W can cause cerebral edema due to its hypotonic nature after metabolism.
• Delirium Tremens: Use with caution in alcohol-dependent patients; thiamine should be administered before or with dextrose to prevent Wernicke’s Encephalopathy.
• Severe Hyperglycemia: Clearly contraindicated in patients with diabetic ketoacidosis (DKA) or uncontrolled diabetes.
• Known Hypersensitivity: Rare, but possible due to corn-based dextrose sources.

4.2 Potential Adverse Effects

1. Hyperglycemia: Excessive infusion can lead to osmotic diuresis, dehydration, and hyperosmolar states.
2. Hyponatremia: Because D5W contains no sodium, rapid or massive infusion can lead to dilutional hyponatremia, which can cause cerebral edema, seizures, and death.
3. Phlebitis: The low pH (3.5–6.5) and hypertonicity of concentrated dextrose can cause irritation of the vascular endothelium.
4. Fluid Overload: Increased risk in patients with congestive heart failure (CHF) or renal impairment.

4.3 Drug Interactions

• Blood Products: D5W should never be administered through the same IV line as blood products, as the hypotonicity can cause hemolysis (clumping/rupture) of red blood cells.
• Phenytoin: Incompatible with D5W; precipitation occurs.
• Ampicillin: Stability is significantly reduced in D5W compared to Normal Saline.

5. Pregnancy and Lactation

• Pregnancy: D5W is generally considered safe for use in pregnancy. However, maternal hyperglycemia can lead to fetal hyperglycemia and subsequent fetal hyperinsulinemia, which may cause neonatal hypoglycemia upon delivery.
• Lactation: No specific contraindications exist for use during breastfeeding, provided maternal fluid and electrolyte balance is maintained.

6. Overdose Management

Overdose of D5W typically manifests as Hyperglycemia and Fluid Overload.

1. Stop Infusion: Immediate cessation of the IV fluid.
2. Insulin Therapy: If hyperglycemia is severe or symptomatic, IV insulin may be required to facilitate glucose uptake.
3. Diuresis: Loop diuretics (e.g., Furosemide) may be utilized if fluid overload is present, provided the patient has adequate renal function.
4. Electrolyte Correction: Monitor serum sodium levels closely. If hyponatremia has developed, hypertonic saline (3% NaCl) may be indicated in symptomatic cases.

7. Frequently Asked Questions (FAQ)

Q1: Is D5W an isotonic solution?

A: In the bag, yes (approx. 252 mOsm/L). In the body, no. Once the dextrose is metabolized, it becomes free water, which is hypotonic to plasma.

Q2: Can I give D5W with blood transfusions?

A: Absolutely not. The hypotonic nature of the solution can cause red blood cells to swell and burst (hemolysis). Use only 0.9% Normal Saline for blood products.

Q3: Why is it used for patients with high sodium?

A: D5W provides "free water." By infusing it, you dilute the sodium concentration in the extracellular fluid, helping to correct hypernatremia.

Q4: Does D5W provide enough calories for a patient who cannot eat?

A: No. D5W provides only 170 kcal per liter. A standard adult requires 1,500–2,000+ kcal/day. It is a bridge, not a nutritional solution.

Q5: What is the risk of "Third Spacing" with D5W?

A: Because it becomes free water, it leaves the intravascular space rapidly. If given in large volumes, it can lead to peripheral edema and pulmonary edema.

Q6: Do I need to worry about the pH of D5W?

A: Yes, D5W is acidic (pH 3.5–6.5). If infused peripherally for long durations, it can cause vein irritation.

Q7: Can D5W cause brain swelling?

A: Yes, if infused too rapidly in patients with neuro-trauma or pre-existing cerebral edema, as the free water moves into the brain cells.

Q8: Should I use D5W in a patient with a head injury?

A: Generally, no. Isotonic fluids like Normal Saline are preferred in neuro-critical care to maintain osmotic balance and prevent cerebral edema.

Q9: What happens if I stop D5W abruptly in a patient on insulin?

A: This can lead to rebound hypoglycemia. Always taper or transition to oral intake carefully.

Q10: Is D5W compatible with all IV medications?

A: No. Many medications, such as phenytoin, are incompatible. Always consult a drug compatibility chart (e.g., Trissel’s) before mixing.

8. Clinical Best Practices Summary

1. Monitor Blood Glucose: Check glucose levels regularly, especially in patients with diabetes or those receiving high-volume infusions.
2. Assess Volume Status: Monitor Intake/Output (I&O) and lung sounds to prevent fluid overload.
3. Site Assessment: Inspect IV sites for signs of phlebitis or infiltration.
4. Compatibility Check: Always verify compatibility with existing infusions via the hospital’s pharmacy protocol.
5. Thiamine First: In cases of suspected malnutrition or alcohol use disorder, always administer thiamine before or concurrent with dextrose to prevent neurological complications.

Disclaimer: This document is for educational purposes only and does not supersede institutional policies or the clinical judgment of a licensed healthcare provider. Always refer to the specific package insert and hospital formulary guidelines for administration.